正电子发射断层显像在胰腺癌与胆囊癌中的作用
本文综述18F-FDG-PET在胰腺外分泌恶性肿瘤中的临床应用,指出其与传统影像互补,在检测敏感性及特异性上相似甚至更优,联合腹部增强解剖影像可提高诊断准确性并辅助分期、可切除性评估、放疗计划及预后判断。FDG摄取程度反映组织病理、侵袭性、转移潜能及代谢特征;治疗后可用于检测残留或复发并监测不可切除或转移性疾病的治疗反应。胆囊癌通常FDG高摄取,解剖影像不明确时PET可高特异性评估转移并指导后续管理。
要点
- 18F-FDG-PET与传统影像互补,联合腹部增强影像可提高胰腺癌诊断准确性与分期能力。
- FDG摄取程度与胰腺导管腺癌的组织病理、侵袭性、转移潜能及代谢特征相关。
- 治疗后FDG-PET可用于检测胰腺癌残留或复发,并监测不可切除或转移性疾病的治疗反应。
核心结论
- 18F-FDG-PET是胰腺外分泌恶性肿瘤传统影像的互补手段,在检测敏感性及特异性上相似甚至更优。
- FDG-PET联合腹部增强解剖影像可提高诊断准确性并辅助分期、可切除性评估、放疗计划与预后判断。
- 胆囊癌通常FDG高摄取,解剖影像不明确时PET可高特异性评估转移并指导后续管理。
研究设计与样本
- 本文为综述,围绕18F-FDG-PET在胰腺癌与胆囊癌中的应用进行总结。
主要发现
- FDG摄取程度反映胰腺导管腺癌的组织病理、侵袭性、转移潜能及代谢特征,并涉及恶性细胞与癌基质的相互作用。
- 治疗后FDG-PET有助于检测胰腺癌残留或复发,并可用于评估和监测不可切除或转移性疾病的治疗反应。
- FDG摄取的 degree 与模式结合其他影像特征,有助于表征偶发胰腺病变及炎症等良性过程。
- 已有多种新型PET放射性药物被开发用于改善胰腺癌的检测与管理。
临床怎么用
- 临床怀疑胰腺外分泌恶性肿瘤时,可将18F-FDG-PET作为传统影像的补充,并与腹部增强解剖影像联合判读。
- 胰腺癌治疗后可用FDG-PET检测残留或复发,并监测不可切除或转移性疾病的治疗反应。
- 胆囊癌解剖影像不明确时,可用FDG-PET高特异性评估转移并指导后续管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
18F-FDG-PET is complementary to conventional imaging in patients with clinical suspicion for exocrine pancreatic malignancies. It has similar if not superior sensitivity and specificity for detection of cancer, and when combined with contrast enhanced anatomic imaging of the abdomen, can improve diagnostic accuracy and aid in staging, assessment for resectability, radiation therapy planning, and prognostication. Various metabolic pathways affect FDG uptake in pancreatic ductal adenocarcinoma. The degree of uptake reflects histopathology, aggressiveness, metastatic potential, and metabolic profile of malignant cell and their interaction with cancer stroma. After treatment, FDG-PET is useful for detection of residual or recurrent cancer and can be used to assess and monitor response to therapy in unresectable or metastatic disease. The degree and pattern of uptake combined with other imaging features are useful in characterization of incidental pancreatic lesions and benign processes such as inflammation. Several novel PET radiopharmaceuticals have been developed to improve detection and management of pancreatic cancer. Gallbladder carcinoma is typically FDG avid and when anatomic imaging is equivocal PET can be used to assess metastatic involvement with high specificity and inform subsequent management.
引用
- Moradi F, Iagaru A. The Role of Positron Emission Tomography in Pancreatic Cancer and Gallbladder Cancer. Semin Nucl Med. 2020. PMID: 32768007. doi:10.1053/j.semnuclmed.2020.04.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。